Involvement of inducible costimulator in the exaggerated memory B cell and plasma cell generation in systemic lupus erythematosus
A Hutloff, K Büchner, K Reiter… - … : Official Journal of …, 2004 - Wiley Online Library
Arthritis & Rheumatism: Official Journal of the American College …, 2004•Wiley Online Library
Objective In systemic lupus erythematosus (SLE), the increased generation of memory B
cells and plasma cells leads to autoimmune hypergammaglobulinemia and destructive
immunoglobulin deposits in the kidneys. We undertook this study to determine the biologic
mechanism driving this overactivation of the B cell compartment, which is the central issue in
SLE. Methods We used flow cytometry to analyze expression of the T cell–specific inducible
costimulator (ICOS) and its ligand (ICOS‐L) on B cells obtained from the peripheral blood of …
cells and plasma cells leads to autoimmune hypergammaglobulinemia and destructive
immunoglobulin deposits in the kidneys. We undertook this study to determine the biologic
mechanism driving this overactivation of the B cell compartment, which is the central issue in
SLE. Methods We used flow cytometry to analyze expression of the T cell–specific inducible
costimulator (ICOS) and its ligand (ICOS‐L) on B cells obtained from the peripheral blood of …
Objective
In systemic lupus erythematosus (SLE), the increased generation of memory B cells and plasma cells leads to autoimmune hypergammaglobulinemia and destructive immunoglobulin deposits in the kidneys. We undertook this study to determine the biologic mechanism driving this overactivation of the B cell compartment, which is the central issue in SLE.
Methods
We used flow cytometry to analyze expression of the T cell–specific inducible costimulator (ICOS) and its ligand (ICOS‐L) on B cells obtained from the peripheral blood of SLE patients. We correlated ICOS‐L expression with the differentiation status of the B cells using a large panel of surface antigens. In addition, SLE kidneys were analyzed by immunohistology.
Results
We found an increased expression of ICOS on CD4+ as well as CD8+ T cells in SLE. At the same time, we documented a down‐regulation of ICOS‐L on a high proportion of peripheral blood memory B cells. Based on in vitro experiments, we inferred that this ICOS‐L down‐regulation on B cells was a signature of recent interaction with ICOS+ T cells in vivo. In the kidneys of SLE patients, we found clusters of B cells and plasma cells in close contact with ICOS+ T cells.
Conclusion
Detailed analysis of B cells with down‐regulated ICOS‐L suggests that ICOS is one of the forces driving the formation of memory B cells and plasma cells in SLE. Furthermore, our identification of plasma cells in areas of T cell–B cell interaction in kidneys suggests that components of a T cell–driven B cell activation process may take place in peripheral tissues in SLE.
Wiley Online Library